HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma

被引:126
作者
Han, Liz Y. [1 ]
Fletcher, Mavis S. [5 ]
Urbauer, Diana L. [2 ]
Mueller, Peter [2 ]
Landen, Charles N. [1 ]
Kamat, Aparna A. [1 ]
Lin, Yvonne G. [1 ]
Merritt, William M. [1 ]
Spannuth, Whitney A. [1 ]
Deavers, Michael T. [3 ]
De Geest, Koen [6 ]
Gershenson, David M. [1 ]
Lutgendorf, Susan K. [7 ]
Ferrone, Soldano [8 ]
Sood, Anil K. [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[5] Univ Nebraska, Dept Pathol, Omaha, NE 68182 USA
[6] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
[7] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA
[8] SUNY Buffalo, Roswell Pk Canc Ctr, Dept Immunol, Buffalo, NY USA
关键词
D O I
10.1158/1078-0432.CCR-07-4433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Defects in the antigen processing machinery (APM) may provide tumor cells with a mechanism to escape immune recognition. The purpose of this study is to determine the clinical significance of APM component down-regulation and tumor-infiltrating T cells in ovarian carcinoma. Experimental Design: After institutional review board approval, tumor samples from 150 patients with invasive epithelial ovarian cancers were examined for TAP1,TAP2, tapasin, HLA class I heavy chain (HLA-HC), beta 2 microglobulin, and T-cell (CD3(+) and CD8(+)) tumor infiltration using immunohistochemistry. Results: The majority of tumors had either heterogeneous or positive expression of TAP1,TAP2, HLA-HC, and 32 microglobulin (66.7%, 73.3%,70.7%, and 63.3%, respectively), except tapasin for which 58% of the tumors lacked expression. Furthermore, 67% and 88% of the lesions possessed intratumoral and peritumoral CD3(+) or CD8(+) cells, respectively. The majority of APM component expression examined was significantly associated with both intratumoral and peritumoral T-cell infiltration (P < 0.05). The expression of APM components and the presence of intratumoral T-cell infiltrates were significantly associated with improved survival (all P <= 0.01); however, peritumoral T-cell infiltrates did not significantly affect survival (P = 0.33). APM component down-regulation (P < 0.001), lack of intratumoral T-cell infiltrates (P = 0.03), and suboptimal cytoreduction (P < 0.001) were independent prognostic markers for death from ovarian carcinoma. Conclusion: The negative effect of APM component down-regulation by itself and in combination with absent intratumoral T-cell infiltration on the survival of patients with ovarian carcinoma implies a role for immune escape in addition to immunosurveillance in the clinical course of disease.
引用
收藏
页码:3372 / 3379
页数:8
相关论文
共 38 条
[1]   Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].
Agarwal, R ;
Kaye, SB .
NATURE REVIEWS CANCER, 2003, 3 (07) :502-516
[2]  
[Anonymous], CANC FACTS FIG 2007
[3]   Mhc class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma [J].
Atkins, D ;
Breuckmann, A ;
Schmahl, GE ;
Binner, P ;
Ferrone, S ;
Krummenauer, F ;
Strökel, S ;
Seliger, B .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (02) :265-273
[4]   The structure of the T cell antigen receptor [J].
Bentley, GA ;
Mariuzza, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :563-590
[5]   Cancer immunotherapy: A treatment for the masses [J].
Blattman, JN ;
Greenberg, PD .
SCIENCE, 2004, 305 (5681) :200-205
[6]   HLA class I antigen loss, tumor immune escape and immune selection [J].
Campoli, M ;
Chang, CC ;
Ferrone, S .
VACCINE, 2002, 20 :A40-A45
[7]   HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis? [J].
Chang, CC ;
Campoli, M ;
Ferrone, S .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) :644-650
[8]  
Cooper BC, 2002, CLIN CANCER RES, V8, P3193
[9]   Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors [J].
Facoetti, A ;
Nano, R ;
Zelini, P ;
Morbini, P ;
Benericetti, E ;
Ceroni, M ;
Campoli, M ;
Ferrone, S .
CLINICAL CANCER RESEARCH, 2005, 11 (23) :8304-8311
[10]   Molecular interactions between extracellular components of the T-cell receptor signaling complex [J].
Garcia, KC .
IMMUNOLOGICAL REVIEWS, 1999, 172 :73-85